Sugi Predict

Sugi Predict / Compounds / Enalapril

Enalapril

Enalapril

SCHEMBL825430

CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Enalapril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ACE known ✓ P12821 14/20 0.91
▸ SMN1; SMN2 Q16637 1/20 1.00
▸ LMNA P02545 2/20 0.91
▸ ABCB11 O95342 2/20 0.65
▸ MEN1 O00255 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ USP2 O75604 1/20 0.63
▸ CYP3A4 P08684 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ PDE3A Q14432 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Enalapril SCHEMBL20817249 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL10 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL2719411 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL9 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL6155137 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL10390115 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL1650291 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL308603 1.00 SMN1; SMN2 (1.00) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL9019924 0.99 SMN1; SMN2 (0.98) SMN1; SMN2ACELMNAABCB11MEN1
Enalapril SCHEMBL9019927 0.99 SMN1; SMN2 (0.98) SMN1; SMN2ACELMNAABCB11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150366813-A1 LIQUID-FILLED IMMEDIATE RELEASE SOFT GELATIN CAPSULES PATHEON SOFTGELS INC 2015-12-24 — — US disclosed
WO-2015195990-A1 LIQUID-FILLED IMMEDIATE RELEASE SOFT GELATIN CAPSULES BANNER LIFE SCIENCES LLC (US) 2015-12-23 — — WO disclosed
EP-2585051-A2 PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING LERCANIDIPINE AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2013-05-01 — — EP disclosed
WO-2011161223-A2 PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING LERCANIDIPINE AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2011-12-29 — — WO disclosed
US-20110212090-A1 Combinatorial Analysis and Repair DAKO DENMARK A/S 2011-09-01 — — US disclosed